Home›Companies›Biotech & Pharma›Trethera

Trethera Corp

Updated Oct 27, 2026·Latest SEC filing May 2, 2025·Suggest an edit

About Trethera

Trethera is a private company based in Sherman Oaks, California. It has reported $35,054,115 raised in eight offerings on Form D since April 2015. Its chief executive is Kenneth Schultz, M.D..

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 29, 2025May 2, 2025$250,000of $5.0M target1$250KEquityRule 506(c)Form D ↗
Jun 26, 2021May 17, 2022$3,833,592target not set38$100KEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Feb 25, 2020Feb 24, 2021$3,253,368fully sold25$130KEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Apr 5, 2019Apr 17, 2019$580,500of $10.0M target5$116KEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Mar 8, 2019Mar 11, 2019$8,056,505fully sold28$287KEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Feb 23, 2017Mar 7, 2017$4,175,557of $5.0M target19$219KEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Feb 10, 2016Feb 23, 2016amended Oct 20, 2016$10,049,743of $20.0M target43$233KEquity, Options, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
Apr 10, 2015Apr 17, 2015amended Jul 2, 2015$4,854,850of $6.0M target26$186KEquity, Debt, Options, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
Total, eight offerings$35,054,115

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Trethera's Form D filed May 2, 2025.

LG
Louis Gonda
Director
KD
Kenneth Schultz, M.D.
CEO and director
LD
CM
Carl McKinzie
Director
Also a member of the board at Athos Therapeutics.
RQ
R. Quinnell
Director

Earlier filings also listed Jean deKernion (executive officer and director, last listed May 2022), Lynne Rollins (executive officer, last listed Apr 2019), Owen Witte, M.D. (director, last listed Mar 2017), Nathan Mata (executive officer, last listed Mar 2017), Johanna Holldack (executive officer and director, last listed Mar 2017), Johannes Czernin (director, last listed Oct 2016) and Caius Radu (director, last listed Oct 2016).

Sources

  1. SECTrethera Corp Form D, filed Feb 23, 2016
  2. SECTrethera Corp Form D, filed Apr 17, 2015
  3. SECTrethera Corp filing history